DBV Technologies S.A. (DBVT) Q2 2026 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Dbv Technologies Sa.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.950 -- 00:00:06.174 Welcome to the DBV second quarter 2026 results and 00:00:06.174 -- 00:00:12.239 business update conference call. All participants will be in a listen-only mode. 00:00:12.239 -- 00:00:17.283 Should you need assistance, please signal a conference specialist by pressing the star 00:00:17.283 -- 00:00:22.967 key followed by zero. After today's presentation, there will be an opportunity 00:00:22.967 -- 00:00:28.431 to ask questions. To ask a question, you may press star, then 00:00:28.431 -- 00:00:33.688 one on your telephone keypad. To withdraw your question, please press 00:00:33.688 -- 00:00:39.410 star, then two. Please note, this event is being recorded. 00:00:39.410 -- 00:00:44.812 I would now like to turn the conference over to Jonathan Neely, Investor Relations. 00:00:44.812 -- 00:00:47.432 Please go ahead, sir. 00:00:48.974 -- 00:00:49.954 Thank you. 00:00:49.954 -- 00:00:54.476 This afternoon, DBV Technologies reported financial results for the second quarter and 00:00:54.476 -- 00:00:59.498 half year of 2026. This update is available in the press releases section of the DBV 00:00:59.498 -- 00:01:04.617 Technologies website. Before we begin, please note that today's call may include a number 00:01:04.617 -- 00:01:09.059 of forward-looking statements, including but not limited to comments regarding our forecast 00:01:09.059 -- 00:01:14.261 of estimated cash runway, clinical and regulatory development plans, the design and conduct 00:01:14.261 -- 00:01:19.464 of our clinical trials, the timing and results of interactions with regulatory agencies, 00:01:19.464 -- 00:01:23.165 and the ability of any of our product candidates, if approved, to improve the lives of 00:01:23.165 -- 00:01:25.577 patients with food allergies. 00:01:25.5...